Related Experiment Video
Updated: Jun 12, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
P wave dispersion in familial Mediterranean fever
Naomi Nussinovitch1, Avi Livneh, Keren Katz
1Hypertension Unit and Department of Internal Medicine D, Sheba Medical Center, Tel Hashomer, Israel. nussim@clalit.org.il
Abstract:
Familial Mediterranean fever (FMF) is a hereditary disease characterized by recurrent and self-terminated attacks of fever and polyserositis. A recent study found that FMF patients had an abnormally high P wave duration and P wave dispersion, markers for supraventricular arrhythmogenicity. The aim of our study was to further evaluate atrial dispersion in FMF patients. The study group consisted of 26 patients with uncomplicated FMF and age- and sex-matched control subjects. All participants underwent 12-lead electrocardiography under strict standards. P wave length and P wave dispersion were computed from a randomly selected beat and from an averaged beat constructed from 7 to 12 beats, included in a 10-s ECG. No statistically significant differences were found between the groups in minimal, maximal, and average P wave duration and P wave dispersion calculated either from a random beat or averaged beats. During 6 months of follow-up, no supraventricular arrhythmias were documented in either group. FMF patients who are continuously treated with colchicine and do not develop amyloidosis have normal atrial conduction parameters and therefore seemingly do not have an increased electrocardiographic risk of atrial fibrillation.
Insights
Familial Mediterranean fever (FMF) patients treated with colchicine show normal atrial conduction. This suggests that FMF patients without amyloidosis do not have an increased risk of atrial fibrillation.
Area of Science:
- Cardiology
- Genetics
- Rheumatology
Background:
- Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
- Previous research indicated potential supraventricular arrhythmogenicity in FMF patients.
- Atrial dispersion is a marker for supraventricular arrhythmias.
Purpose of the Study:
- To investigate atrial dispersion in FMF patients.
- To assess electrocardiographic risk for atrial fibrillation in FMF.
Main Methods:
- 12-lead electrocardiography was performed on 26 FMF patients and controls.
- P wave duration and dispersion were calculated from random and averaged ECG beats.
- A 6-month follow-up was conducted to monitor for arrhythmias.
Main Results:
- No significant differences in P wave duration or dispersion were found between FMF patients and controls.
- No supraventricular arrhythmias were detected in either group during follow-up.
- Colchicine treatment and absence of amyloidosis correlated with normal atrial conduction.
Conclusions:
- Uncomplicated FMF patients on colchicine without amyloidosis exhibit normal atrial conduction.
- These FMF patients do not appear to have an elevated electrocardiographic risk of atrial fibrillation.
- Further research may clarify the long-term cardiac implications of FMF.
Related Concept Videos
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Pericarditis I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
